The multicenter study on heart failure treatment with intrathoracic impedance: MOMOTARO II study (MOnitoring and Management of OpTiVol Alert to Reduce heart failure hOspitalization)
- Conditions
- Patient who has organic heart disease and requiring ICD or CRTD. Patient received ICD or CRTD. 1) Patient with less than 40% of LVEF 2) Patient with past history of heart failure
- Registration Number
- JPRN-UMIN000012714
- Lead Sponsor
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Brief Summary
Our ITI algorithm could properly find slight fluid retention without apparent symptom. Early intervention, such as lifestyle modification, diuretics or nitrates, for asymptomatic HF patients diagnosed by our ITI algorithm could improve the condition of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 156
Not provided
1) Patient under 20 years old. 2) Patient with moderate or severe chronic obstructive lung disease (forced expiratory volume < 1.0 L/s). 3) Patient who is received heart transplantation or is supposed to receive heart transplantation. 4) Patient with primary pulmonary hypertension. 5) Patient with renal failure of stage IV or V. (GFR <15 mL/min/1.73 m^2) 6) Patient under one year of life expectancy. 7) Patient with pregnancy or possible pregnancy. 8) Patient in whom doctor think inadequate. 9) Patient with heart failure in enrollment. 10) Severe heart failure patients with necessity of hospitalization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method